Navigation Links
Ambry Genetics Announces Launch of Their StemArray(TM) Product and Services for High Resolution Characterization of Human Stem Cells

ALISO VIEJO, Calif., Jan. 20 /PRNewswire/ -- Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome.  The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs. The 44K array offers increased coverage in known stem cell and cancer associated genes to further enhance the resolution in these functionally important regions.


"The StemArray™ is the solution for stem cell scientists that are working with Human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells in order to detect genomic abnormalities found in stem cells that would be missed by low resolution karyotyping," said Ardy Arianpour, Ambry's Director of Business Development. "We are offering the StemArray™ at a comparable cost to traditional karyotyping and strongly believe that the product and our service will help scientists with new discoveries within this market."

Human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells that are cultured for an extended period of time are susceptible to chromosomal instability, which is a big concern for researchers. Currently, stem cells have been characterized mainly through traditional low-resolution karyotypic analyses, which can only identify large scale aneuploidies over 5 MB in size. The Ambry StemArray™ has an average resolution of 43KB throughout the genome and 24KB in RefSeq genes. Resolution is even further enhanced, to the exonic level, in stem cells and cancer related genes.

"As human stem cells begin to make their way into clinical studies, it is essential that the cell lines be thoroughly characterized, added Dr. Aaron Elliott, Ambry's R&D Scientist, Genomics. Using the StemArray™ scientists will not only detect the extremely large copy number changes that can be found by karyotype, but also identify very small aberrations that occur during culture that could decrease the reproducibility and reliability of experimental data."

The Ambry StemArray™ is ready to be ordered and processed today. For more information on the StemArray™ and the full line of Ambry's genomic services, please visit our website at

About Ambry Genetics

Ambry Genetics is a CAP-accredited, GLP-compliant, CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research. To learn more about testing and services available through Ambry, visit

SOURCE Ambry Genetics



SOURCE Ambry Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
2. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at
3. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
4. deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets
5. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
6. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
7. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
8. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
9. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
10. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
11. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
Post Your Comments:
(Date:11/25/2015)... 25, 2015  The American Academy of Pediatrics ... and the March of Dimes cheered today,s signature ... Infants Act of 2015 (S.799), which takes ... born exposed to drugs, such as opioids, and ... all three organizations have worked together leading advocacy ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... Ltd. (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical ... the simultaneous treatment of various clinical conditions, today announced ... of 3,158,900 American Depository Shares ( ADSs ), each ... to purchase up to 3,158,900 ADSs. The ADSs and ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... 29, 2015 , ... Effective immediately, every single IguanaMed scrub style will be ... Target is offering a “Buy One Scrub Set, Get the 2nd Scrub Set 50% ... IguanaMed at a discounted price. , IguanaMed’s mission is to outfit every ...
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may not ... from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there is ... the expense of having to replace NuvaRings more often than necessary. As such, it ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):